These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4948431)

  • 1. Clinical experimentation with apomorphine in Parkinson's disease.
    Castaigne P; Laplane D; Dordain G
    Res Commun Chem Pathol Pharmacol; 1971 Mar; 2(2):154-8. PubMed ID: 4948431
    [No Abstract]   [Full Text] [Related]  

  • 2. Apomorphine for the acute treatment of "off" episodes in Parkinson's disease.
    Stacy M; Silver D
    Parkinsonism Relat Disord; 2008; 14(2):85-92. PubMed ID: 18083605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment for people with Parkinson's.
    FDA Consum; 2004; 38(4):5. PubMed ID: 15346564
    [No Abstract]   [Full Text] [Related]  

  • 4. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
    [No Abstract]   [Full Text] [Related]  

  • 5. Future delivery systems for apomorphine in patients with Parkinson's disease.
    van Laar T; Van der Geest R; Danhof M
    Adv Neurol; 1999; 80():535-44. PubMed ID: 10410768
    [No Abstract]   [Full Text] [Related]  

  • 6. Apomorphine (Apokyn) for advanced Parkinson's Disease.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):7-8. PubMed ID: 15647705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine].
    Merello M; Leiguarda R
    Medicina (B Aires); 1995; 55(1):5-10. PubMed ID: 7565037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subcutaneous apomorphine in the treatment of Parkinson's disease].
    Linazasoro G
    Neurologia; 1994 Jan; 9(1):1-3. PubMed ID: 8161461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apomorphine and Parkinson's disease. A major therapeutical progress].
    Pollak P; Gervason CL; Deffond D; Perret JE
    Rev Prat; 1992 Mar; 42(5):591-3. PubMed ID: 1604186
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous subcutaneous apomorphine infusion in Parkinson's disease.
    Simpkin DM; Milner R; Snell AP
    Med J Aust; 1992 Jun; 156(12):883-4. PubMed ID: 1603020
    [No Abstract]   [Full Text] [Related]  

  • 11. Apomorphine increases blood glucose concentrations in Parkinson's disease.
    Tison F; Fouillet N; Henry P
    Clin Neuropharmacol; 1994 Feb; 17(1):92-5. PubMed ID: 8149364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aporphines in Parkinson's disease.
    Cotzias GC; Papavasiliou PS; Tolosa E; Bell-Midura MA; Ginos JZ
    Trans Am Neurol Assoc; 1975; 100():178-81. PubMed ID: 1226602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apomorphine in the biochemical concept of Parkinson's tremor].
    Brinkmann R; Strian F
    Nervenarzt; 1974 Sep; 45(9):474-6. PubMed ID: 4437688
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ; Obering C
    Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
    Hellmann MA; Sabach T; Melamed E; Djaldetti R
    Biomed Pharmacother; 2008; 62(4):250-2. PubMed ID: 17967525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease.
    Wenning GK; Bösch S; Luginger E; Wagner M; Poewe W
    Adv Neurol; 1999; 80():545-8. PubMed ID: 10410769
    [No Abstract]   [Full Text] [Related]  

  • 17. 10 questions about using apomorphine for Parkinson disease.
    Dewey RB
    Neurologist; 2005 May; 11(3):190-2. PubMed ID: 15860144
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of apomorphine in Parkinson's disease.
    Stocchi F
    Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of apomorphine in clinical practice.
    MacMahon DG
    Adv Neurol; 1999; 80():529-33. PubMed ID: 10410767
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease.
    Dewey RB; Maraganore DM; Ahlskog JE; Matsumoto JY
    Mov Disord; 1998 Sep; 13(5):782-7. PubMed ID: 9756146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.